NIH-funded research R37 grant

Positive psychology support for stem cell transplant survivors

Official title: Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors

Funded at Brigham and Women's Hospital · NIH-11383135 · Data updated 2026-11-12

A phone-delivered program helps people who survived stem cell transplantation feel less anxious or depressed and enjoy a higher quality of life.

More Hematopoietic Stem Cell Transplantation research and trials

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 9, 2024
Project endJune 30, 2029
Funding year2026
Award (this year)$674,952
NIH project number5R37CA288557-03
Project IDNIH-11383135 on NIH RePORTER

Who could benefit from this research

Could help

Hematopoietic stem cell transplantation survivors experiencing anxiety or depression and seeking improvements in mood and quality of life.

Less likely to help

Survivors without significant psychological distress or those who prefer non-psychological approaches may not experience benefit.

What this research studies

This project offers PATH, a 15–20 minute, phone-based program designed to boost positive well‑being by cultivating gratitude, strengths, and meaning for HSCT survivors. It targets anxiety, depression, and overall quality of life, with sessions led by trained interventionists and delivered remotely to increase accessibility. The study will track symptom changes over time to see if this approach provides meaningful relief and better daily functioning for survivors who often face long recoveries and ongoing health concerns.

Why it matters

Potential benefit: If successful, survivors could experience reduced anxiety and depression and improved quality of life through an accessible, low-burden intervention.

How similar studies have gone: Prior positive psychology approaches have shown promise in improving well-being, but tailored, phone-delivered PATH is a novel, scalable option for HSCT survivors.

Where this research is happening

  • Brigham and Women's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Amonoo, Hermioni L. — Brigham and Women's Hospital
  • Study coordinator: Amonoo, Hermioni L.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.